Saturday, August 29, 2026 See who Washington just made rich Go Pro · $40/mo →
Money Racket
Who Cashes In When Washington Moves
HEALTHCARE & FDAFDA Authorizes Generic Bimectin for Screwworm PreventiontodayDEFENSEPentagon Awards Largest F-35 Spare Parts Contract—Lockheed Locks in Sustainment Revenue4 weeks agoHEALTHCARE & FDAFDA Opens GenAI Medical Device Regulation to Public InputtodayDEFENSEHouse Passes $1.15T Defense Bill—Lockheed, Raytheon, General Dynamics Lock in Revenue4 weeks agoHEALTHCARE & FDATrump Admin Blocks $1.6B in Fraudulent Medicare Lab PaymentstodayMARKETSSEC Explores 23-Hour Stock Trading—Market Makers and Tech Platforms Get New Revenue4 weeks agoTECHNHTSA Extends Comment Period on Vehicle Safety ExemptionstodayENERGYPHMSA Updates Pipeline Safety Standards—Compliance Costs Hit Operators, Benefit Inspectors4 weeks agoENERGYBLM Launches 30-Year Permit for Trans-Alaska Pipeline OperationsyesterdaySEARCH DEMANDCasgevy List Price: $2.2 Million4 weeks agoMARKETSFTC Blocks Henkel's $725M Liquid Nails Bid—Antitrust WinsyesterdaySEARCH DEMANDData Center Power Exchange4 weeks agoHEALTHCARE & FDAFDA Approves First RAS Inhibitor for Pancreatic Cancer2 days agoTRADE & TARIFFSAmazon Gets $600M Tariff Refund—Retailers Lift Guidance on Windfall4 weeks agoDEFENSEBoeing Lands $131B F-15 Contract—Fighter Jet Dominance2 days agoTECHCommerce Awards $874M in Semiconductor R&D LOIs—Chip Makers Get Federal Backing4 weeks agoHEALTHCARE & FDACostco Enters Medicare Advantage—Retail Disruption Looms2 days agoHEALTHCARE & FDAFDA Revokes Petroleum-Based Food Dyes—Natural Color Makers Win4 weeks agoTRADE & TARIFFSTrump's 50% Canada Tariffs Take Effect—Retailers Brace2 days agoDEFENSEHouse Passes $95B Iran War Package—Defense Contractors Lock in Revenue4 weeks agoTRADE & TARIFFSU.S. Rolls Out Iran Sanctions—Oil Prices Slip2 days agoWHITE HOUSETrump Blocks Critical Minerals Exports—U.S. Miners Get Protected Market4 weeks agoHEALTHCARE & FDAAbbott's Dual Glucose-Ketone Monitor Wins FDA Nod3 days agoHEALTHCARE & FDAHumana Exits MA Markets—600K Members Face Plan Disruption4 weeks agoHEALTHCARE & FDARegeneron's Gene Therapy Wins First GSD Type Ia Approval3 days agoENERGYMichigan Court Vacates Line 5 Permit—Enbridge Faces Shutdown Risk4 weeks agoDEFENSEStryker Lands $100M Defense Contract—Combat Vehicle Boost3 days agoTRADE & TARIFFSAmazon Pockets $600M Tariff Refund—Retail Rivals Face Margin Squeeze3 weeks agoTRADE & TARIFFSWalmart Deploys $2.9B Tariff Refund Into Price Cuts3 days agoHEALTHCARE & FDAHHS Boosts Hospital Payments by $2 Billion—Acute Care Operators Win3 weeks agoTRADE & TARIFFSTrump Lifts Ground Beef Tariffs—Ranchers Face Price Pressure3 days agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Drug Plan Insurers Face Margin Pressure3 weeks agoWHITE HOUSETrump Kills Affirmative Action Rules—Contractors Face Compliance Shift4 days agoHEALTHCARE & FDACMS Raises IRF Payments for 2027—Rehab Hospitals Get Relief3 weeks agoHEALTHCARE & FDAFDA Clears Robotic Blood Draw—Phlebotomy Shortage Eases4 days agoTRADE & TARIFFSTrump Administration Hits $100B Tariff Refund Milestone3 weeks agoWHITE HOUSELabor Dept Eases Disability Hiring Rules—Contractors Save Compliance Costs4 days agoDEFENSERising Defense Spending Lifts Northrop Grumman Outlook3 weeks agoWHITE HOUSELabor Dept Eases Veteran Hiring Rules—Contractors Cut Compliance4 days agoMARKETSFTC Threatens Booking Holdings Over Priceline Practices3 weeks agoTECHCHIPS Act Transforms Binghamton Into Semiconductor Hub5 days agoHEALTHCARE & FDAFTC Sues Hims & Hers Over Privacy and Billing Practices3 weeks agoTRADE & TARIFFSTrump Administration Targets Iran's Banking System With New Sanctions5 days agoHEALTHCARE & FDAFDA Approves Tudriqev for Advanced Melanoma3 weeks agoTECHUtah Governor Signs Quantum Computing Initiative Order5 days agoTRADE & TARIFFSRetailers Sell Off Tariff Refund Rights for Cash—Windfall Monetized Before Payout3 weeks agoDEFENSEFAA Engine Inspection Order Lifts MRO Stocks6 days agoTECHU.S. Signs $874M Semiconductor Research LOIs—Chip Makers Get Federal Backing3 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earnings6 days agoWHITE HOUSEDHS Tightens H-1B/L-1 Visa Fees—Tech Hiring Costs Rise for Employers3 weeks agoHEALTHCARE & FDATrump Vaccine Spacing Order Reshapes Pharma Demand6 days agoENERGYMichigan Court Rejects Enbridge Line 5 Permit Under Great Lakes3 weeks agoTECHD-Wave Wins Canadian Quantum Funding for Annealing6 days agoDEFENSEPentagon Awards Space-Based Target Tracking Contracts3 weeks agoENERGYEnbridge Wins Federal Permit for Line 5 Tunnellast weekTECHTrump Administration Adds 6 Chipmakers to U.S. Portfolio3 weeks agoENERGYFederal Court Orders Enbridge Line 5 Removallast weekWHITE HOUSEWhite House Drafts Vaccine-Autism Order—Pharma Faces Uncertainty3 weeks agoWHITE HOUSEFinCEN Finalizes BOI Exemption for U.S. Personslast weekDEFENSETrump Pushes $1.5T Defense Budget—Lockheed, RTX, GD Lock in Gains3 weeks agoHEALTHCARE & FDAGAO Finds $7.6B Medicare Hospice Overpaymentlast weekWHITE HOUSETrump Order Splits MMR Vaccine—Pharma Faces Demand Shift3 weeks agoENERGYNewsom Passes Diablo Canyon Decision to Successorlast weekWHITE HOUSETrump Orders Childhood Vaccine Schedule Spacing2 weeks agoDEFENSERTX Lands Fresh Missile Defense Contract—Stock Undervaluedlast weekHEALTHCARE & FDAFDA Updates Fresh-Cut Produce Safety Guidance2 weeks agoTECHCommerce Eases Drone Export Rules—U.S. Makers Winlast weekENERGYNRC Approves NAC MAGNASTOR Spent Fuel Storage Cask2 weeks agoHEALTHCARE & FDAFDA Reclassifies Cancer Tests—Easier Path for Diagnosticslast weekHEALTHCARE & FDAFDA Clears Screwworm Prevention Drug for U.S. Livestock2 weeks agoHEALTHCARE & FDAFTC Probes Epic Systems Over Health Records Monopolylast weekDEFENSEIonQ Lands $28M U.S. Defense Quantum Contract2 weeks agoDEFENSETrump's $1.5T Defense Push Fuels Colorado Contractor Windfalllast weekTECHFCC Eases Broadband Label Rules—ISPs Win Flexibility2 weeks agoENERGYEPA Exempts Calcium Carbonate From Pesticide Tolerance—Farm Input Easeslast weekDEFENSEBlackSky Lands Multi-Year Satellite Contract2 weeks agoWHITE HOUSETrump Vaccine Spacing Order Reshapes Pharma Demandlast weekHEALTHCARE & FDASimparica Trio Gets Screwworm EUA—Zoetis Wins2 weeks agoHEALTHCARE & FDACMS Ends Medicare Part D Subsidy—Insurers Face Pressurelast weekTRADE & TARIFFSTrump Tariffs on Drones Boost U.S. Makers2 weeks agoTRADE & TARIFFSTariff Refunds Flow to Retailers—Earnings Boostlast weekTRADE & TARIFFSKimberly-Clark Pockets $45M Tariff Refund2 weeks agoENERGYArmy Corps Permits Line 5 Tunnel—Michigan Blocks Pathlast weekCRYPTOSEC Delays Crypto Rules—Uncertainty Persists2 weeks agoTRADE & TARIFFSTariff Refunds Turbocharge Retailer Earningslast week
1 free article left this week. A free account gets you 4 a week.Go Pro →
Healthcare & FDA

FDA Authorizes Generic Bimectin for Screwworm Prevention

Emergency approval of generic ivermectin protects cattle herds and breaks single-supplier risk.

Image: Money Racket
By at Money Racket · Aug 29, 2026

The FDA issued an Emergency Use Authorization on August 27, 2026, for Bimectin (ivermectin) injection to prevent New World screwworm infestations in cattle when administered within 24 hours of birth, castration, or wound appearance. The authorization advances the Trump Administration's agricultural protection agenda and ensures producers are not dependent on a single manufacturer.

Generic ivermectin breaks single-supplier risk for cattle producers but leaves Zoetis' premium animal-health franchise untouched.

The primary beneficiary is the U.S. cattle industry—a diffuse but economically significant constituency. More directly, Boehringer Ingelheim (private, German-owned) and any U.S. generic manufacturers producing ivermectin gain market access. If a U.S.-listed generic player like Teva Pharmaceutical (TEVA) or Mylan/Viatris (VTRS) holds or secures manufacturing capacity, they benefit from expanded livestock use and reduced regulatory friction. However, the EUA is temporary and narrowly scoped, limiting upside.

The incumbent supplier—likely Zoetis ZTS, which dominates animal health—faces no material threat. Zoetis' premium-branded products and integrated distribution network insulate it from generic competition in this narrow indication. The EUA actually reduces political pressure on Zoetis by demonstrating regulatory flexibility.

Watch for the EUA's duration and whether it converts to permanent approval. If screwworm risk escalates (climate-driven range expansion), demand for prevention could spike, but the generic authorization caps pricing power. Zoetis' Q4 2026 earnings call will reveal whether management sees this as a competitive threat or a non-event.

Source: original report ↗

Free alerts

Free: catalyst alerts, straight to your inbox.

Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $40/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://moneyracket.com/article/fda-emergency-auth-bimectin-screwworm/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Money Racket Pro

    By the time it's news, the money's already moved.

    The contract award, the executive order, the tariff cut — it mints winners before the financial press connects the dots. Pro gets you there first: what happened, who cashes in, and exactly what to watch — in a two-minute read.

    Go Pro · $40/mo The policy-to-profit brief. Cancel anytime.
    The pre-market brief · Mon–Sat, 7:45am ET Go Pro · $40/mo →